What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001823138
Total reported value
$5.0B
$5.0B
25 檔
8.4%
According to the latest 13F quarterly dataset, Two Seas Capital LP managed an equity portfolio of $5.0B at the end of Q3 2024, spanning 25 distinct U.S. exchange-listed positions.
Two Seas Capital LP executed strategic sector rebalancing during Q3 2024, establishing 6 new positions while fully exiting 1 holdings and trimming 12 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | INDV | Indivior Pharmaceuticals, Inc. | Stock-Other | 20.58% | — | +3.17% | |
| 2 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 18.18% | +3.08% | -5.76% | |
| 3 | TLN | Talen Energy CORP | Stock-Utilities | 12.97% | +1.28% | -3.56% | |
| 4 | CORZ | Core Scientific Inc | Stock-Tech | 10.96% | +3.29% | -8.55% | |
| 5 | EXEL | Exelixis Inc | Stock-Healthcare | 5.72% | — | +1122.82% | |
| 6 | ABUS | Arbutus Biopharma CORP | Stock-Other | 5.23% | +0.65% | -2.15% | |
| 7 | VST | Vistra CORP | Stock-Utilities | 4.85% | +0.96% | -19.55% | |
| 8 | ✓ | Avadel Pharmaceuticals PLC ADR | Stock-Other | 4.79% | — | +6.55% | |
| 9 | META | Meta Platforms Inc-class A | Stock-Comm Services | 3.33% | — | +16.15% | |
| 10 | IMVT | Immunovant Inc | Stock-Other | 3.12% | +1.29% | -2.28% | |
| 11 | ESPR | Esperion Therapeutics Inc | Stock-Other | 1.76% | -0.44% | EXIT | |
| 12 | SHC | Sotera Health Co | Stock-Other | 1.08% | +0.84% | +14.29% | |
| 13 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 1.07% | — | -18.98% | |
| 14 | SONO | Sonos Inc | Stock-Other | 1.05% | +0.02% | -24.86% | |
| 15 | CEG | Constellation Energy | Stock-Utilities | 1.05% | — | — | |
| 16 | CLMT | Calumet Inc | Stock-Other | 0.89% | +1.73% | — | |
| 17 | ESPR 4 11-15-25Bond | Esperion Therapeutics | Bond | 0.82% | — | -73.84% | |
| 18 | ARQT | Arcutis Biotherapeutics Inc | Stock-Other | 0.47% | — | -59.05% | |
| 19 | HUT | Hut 8 CORP | Stock-Financials | 0.41% | +0.20% | — | |
| 20 | PCRX | Pacira Biosciences Inc | Stock-Other | 0.39% | — | — | |
| 21 | IREN | IREN Limited | Stock-Other | 0.38% | +0.13% | NEW | |
| 22 | WULF | Terawulf Inc | Stock-Financials | 0.33% | +1.24% | -13.47% | |
| 23 | CORZW | Core Scientific Inc - 27 | Stock-Other | 0.31% | +0.07% | — | |
| 24 | ✓ | Bit Digital Inc | Stock-Other | 0.23% | — | — | |
| 25 | OMEX | Odyssey Marine Exploration | Stock-Other | 0.01% | +0.02% | -91.31% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EXEL | Exelixis Inc | +5.3% | +1122.82% | Add |
| 2 | TLN | Talen Energy CORP | +4.6% | -3.56% | Trim |
| 3 | CORZ | Core Scientific Inc | +1.5% | -8.55% | Trim |
| 4 | CEG | Constellation Energy | +1.1% | NEW | New buy |
| 5 | ABUS | Arbutus Biopharma CORP | +0.9% | -2.15% | Trim |
| 6 | CLMT | Calumet Inc | +0.9% | NEW | New buy |
| 7 | META | Meta Platforms Inc-class A | +0.8% | +16.15% | Add |
| 8 | VST | Vistra CORP | +0.5% | -19.55% | Trim |
| 9 | ROIV | Roivant Sciences Ltd. | +0.5% | -5.76% | Trim |
| 10 | HUT | Hut 8 CORP | +0.4% | NEW | New buy |
| 11 | SHC | Sotera Health Co | +0.4% | +14.29% | Add |
| 12 | PCRX | Pacira Biosciences Inc | +0.4% | NEW | New buy |
| 13 | IREN | IREN Limited | +0.4% | NEW | New buy |
| 14 | ✓ | Bit Digital Inc | +0.2% | NEW | New buy |
| 15 | IMVT | Immunovant Inc | +0.2% | -2.28% | Trim |
| 16 | CORZW | Core Scientific Inc - 27 | +0.1% | — | Unchanged |
| 17 | WULF | Terawulf Inc | 0% | -13.47% | Trim |
| 18 | ✓ | Avadel Pharmaceuticals PLC ADR | 0% | +6.55% | Add |
| 19 | ESPR | Esperion Therapeutics Inc | -0.3% | +14.80% | Add |
| 20 | CORZZ | Core Scientific Inc - 29 | -0.3% | EXIT | Sold out |
| 21 | GOOGL | Alphabet Inc-cl A | -0.4% | -18.98% | Trim |
| 22 | SONO | Sonos Inc | -0.6% | -24.86% | Trim |
| 23 | ARQT | Arcutis Biotherapeutics Inc | -0.7% | -59.05% | Trim |
| 24 | OMEX | Odyssey Marine Exploration | -0.9% | -91.31% | Trim |
| 25 | ESPR 4 11-15-25Bond | Esperion Therapeutics | -2.2% | -73.84% | Trim |
| 26 | INDV | Indivior Pharmaceuticals, Inc. | -12.5% | +3.17% | Add |
According to official SEC Form 13F filings, Two Seas Capital LP reported a total U.S. public equity portfolio value of $5.0B across 25 disclosed positions in Q3 2024.
During Q3 2024, Two Seas Capital LP's top holdings by market value included INDV (20.6%)、ROIV (18.2%)、TLN (13.0%). The largest single position, INDV, represented 20.6% of total portfolio value.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including INDV, ROIV, TLN) accounted for 8.4% of total reported equity market value during Q3 2024.
Top New Position Initiated
CEG
市值: $6.5M
Top Position Liquidated / Trimmed
CORZZ
前期市值: $2.0M
In Q3 2024, Two Seas Capital LP made 25 total portfolio adjustments, initiating 6 new buys, adding to 6 positions, trimming 12 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.